Search research articles
Contact Us
Filters
Showing results (101-110 of 286) with videos related to
Page
of 29
Sort By:
The Journal of Biological Chemistry
|
April 14, 2023
Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway
Yue Zhou, Ryota Oki, Akihiro Tanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2012
[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective]
Tadaaki Yamada, Koushiro Ohtsubo, Daisuke Ishikawa, et al.
Scientific Reports
|
October 22, 2025
Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway
Khanh Nguyen, Yue Zhou, Satoru Yokoyama, et al.
Chest
|
September 9, 2023
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy
Saya Tsukida, Satoshi Watanabe, Masato Hongo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 14, 2006
[Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin]
Yoshiki Kataoka, Yoshinori Nio, Seiji Yano, et al.
Cancer Science
|
May 6, 2017
Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
Hirokazu Taniguchi, Tadaaki Yamada, Shinji Takeuchi, et al.
International Journal of Cancer
|
December 4, 2010
Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs
Hidenori Tanaka, Tatsuo Kimura, Shinzoh Kudoh, et al.
Japanese Journal of Clinical Oncology
|
July 6, 2010
The role of percutaneous needle biopsy in differentiation of renal tumors
Kouji Izumi, Kazutaka Narimoto, Kazuhiro Sugimoto, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice
Tadaaki Yamada, Hiroaki Muguruma, Seiji Yano, et al.
Cureus
|
September 10, 2025
The Pretreatment Neutrophil-to-Eosinophil Ratio Can Predict Immune-Related Adverse Events and Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
Keita Kobayashi, Shigeru Sakano, Hiroaki Matsumoto, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 286) with videos related to
Sort By:
Page
of 29
The Journal of Biological Chemistry
|
April 14, 2023
Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway
Yue Zhou, Ryota Oki, Akihiro Tanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2012
[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective]
Tadaaki Yamada, Koushiro Ohtsubo, Daisuke Ishikawa, et al.
Scientific Reports
|
October 22, 2025
Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway
Khanh Nguyen, Yue Zhou, Satoru Yokoyama, et al.
Chest
|
September 9, 2023
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy
Saya Tsukida, Satoshi Watanabe, Masato Hongo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 14, 2006
[Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin]
Yoshiki Kataoka, Yoshinori Nio, Seiji Yano, et al.
Cancer Science
|
May 6, 2017
Impact of MET inhibition on small-cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
Hirokazu Taniguchi, Tadaaki Yamada, Shinji Takeuchi, et al.
International Journal of Cancer
|
December 4, 2010
Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs
Hidenori Tanaka, Tatsuo Kimura, Shinzoh Kudoh, et al.
Japanese Journal of Clinical Oncology
|
July 6, 2010
The role of percutaneous needle biopsy in differentiation of renal tumors
Kouji Izumi, Kazutaka Narimoto, Kazuhiro Sugimoto, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice
Tadaaki Yamada, Hiroaki Muguruma, Seiji Yano, et al.
Cureus
|
September 10, 2025
The Pretreatment Neutrophil-to-Eosinophil Ratio Can Predict Immune-Related Adverse Events and Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
Keita Kobayashi, Shigeru Sakano, Hiroaki Matsumoto, et al.
Page
of 29